Nebulized- Swallowed Albuterol for Treatment of Food Impaction in Pediatric Patients with Eosinophilic Esophagitis: A Novel Non-Endoscopic Approach

Key Points

• The study aims to explore the efficacy of nebulized albuterol for managing food impaction in pediatric patients with eosinophilic esophagitis.
• Administered nebulized albuterol (2.5 mg/2 mL) to five children with eosinophilic esophagitis and food impaction.
• Instructed patients to breathe and swallow aerosol condensate.
• Performed endoscopy with biopsies to confirm eosinophilic esophagitis.
• Four out of five patients experienced relief from food impaction after nebulized albuterol treatment.
• Endoscopic evaluations confirmed the diagnosis of eosinophilic esophagitis in all patients.